Get the Stockscreener App
113.83
0.30%
-0.39
Genedx Holdings Corp stock is traded at $113.83, with a volume of 183.59K.
It is down -0.30% in the last 24 hours and down -6.56% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$114.22
Open:
$112.26
24h Volume:
183.59K
Relative Volume:
0.24
Market Cap:
$3.27B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-36.60
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
-12.88%
1M Performance:
-6.56%
6M Performance:
+13.21%
1Y Performance:
+209.11%
1-Day Range:
$110.49
$114.58
1-Week Range:
$110.49
$132.01
52-Week Range:
$36.85
$136.00
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
113.88 | 3.49B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
461.73 | 177.38B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
181.72 | 135.85B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
616.68 | 51.87B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
122.06 | 35.70B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
178.50 | 31.70B | 15.70B | 1.24B | 2.01B | 6.91 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
2.5 Million Patient Records: GeneDx Launches Infinity, Largest Rare Disease Dataset in Genomic Medicine - Stock Titan
Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells 3,728 Shares of Stock - MarketBeat
Katherine Stueland Sells 10,501 Shares of GeneDx (NASDAQ:WGS) Stock - MarketBeat
Harbor Capital Advisors Inc. Purchases 24,042 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
MRA Advisory Group Acquires Shares of 3,229 GeneDx Holdings Corp. $WGS - MarketBeat
Can GeneDx Holdings Corp stock double in the next year2025 Bull vs Bear & Precise Buy Zone Identification - khodrobank.com
GeneDx Holdings Corp. Achieves 222.26% Return, Establishing It as a Multibagger in Biotechnology - Markets Mojo
GeneDx Holdings Corp. Sees Valuation Shift Amid Strong Financial Performance and Growth - Markets Mojo
GeneDx CEO Stueland sells $1.27 million in shares By Investing.com - Investing.com UK
Breakout Zone: What is the long term forecast for GeneDx Holdings Corp Equity Warrant stockJuly 2025 Closing Moves & AI Powered Buy and Sell Recommendations - خودرو بانک
Jacobs Levy Equity Management Inc. Makes New Investment in GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Holdings Corp. $WGS Shares Sold by Goldman Sachs Group Inc. - MarketBeat
GeneDx CEO Stueland sells $1.27 million in shares - Investing.com India
Feeley, GeneDx holdings CFO, sells $453k in shares - Investing.com
Aug Big Picture: Can GeneDx Holdings Corp Equity Warrant stock outperform in a bear market - خودرو بانک
Inflation Data: Can GeneDx Holdings Corp. Equity Warrant outperform in the next rally2025 Pullback Review & Accurate Buy Signal Alerts - خودرو بانک
GeneDx Holdings Appoints Thomas Fuchs to Board - TipRanks
GeneDx Holdings adds Thomas Fuchs as director, expands board to eight members - Investing.com Australia
GeneDx Holdings adds Thomas Fuchs as director, expands board to eight members By Investing.com - Investing.com South Africa
Movement Recap: Will Enact Holdings Inc outperform its industry peersPortfolio Return Summary & Free Community Consensus Stock Picks - khodrobank.com
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Sep 16 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
25,079 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Sep 16 '25 |
Sale |
121.47 |
10,501 |
1,275,585 |
14,578 |
| Stueland Katherine | Chief Executive Officer |
Sep 09 '25 |
Option Exercise |
0.00 |
6,546 |
0 |
9,986 |
| Stueland Katherine | Chief Executive Officer |
Sep 09 '25 |
Sale |
128.06 |
3,657 |
468,297 |
6,329 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 09 '25 |
Option Exercise |
0.00 |
2,462 |
0 |
6,558 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 09 '25 |
Sale |
128.05 |
1,272 |
162,886 |
5,286 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 01 '25 |
Option Exercise |
0.00 |
717 |
0 |
4,474 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 02 '25 |
Sale |
125.81 |
378 |
47,556 |
4,096 |
| Ryan Jason | Director |
Aug 27 '25 |
Sale |
127.30 |
38,072 |
4,846,708 |
103,284 |
| Ryan Jason | Director |
Aug 27 '25 |
Sale |
129.65 |
1,150 |
149,093 |
11,904 |
1.36%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):